<?xml version="1.0" encoding="UTF-8"?>
<p>Soromou et al., also demonstrated that pinocembrin provides in vitro and in vivo protection against LPS induced inflammation and regulates the production of IL-6, IL-10, IL-1β and TNF-α. In vivo, using a mouse model of LPS induced acute lung injury, 20 or 50 mg/kg pinocembrin attenuates the development of pulmonary edema and histological severities [
 <xref rid="B58-plants-09-01464" ref-type="bibr">58</xref>].
</p>
